Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JA Roth
Prm126 - A Comparison of Mixture Cure and Standard Parametric Modeling to Estimate Long-Term Survival for Small-Cell Lung Cancer in Patients Treated With Nivolumab After Progression
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
hTERT Promoter Induces Tumor-Specific Bax Gene Expression and Cell Killing in Syngenic Mouse Tumor Model and Prevents Systemic Toxicity
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Related publications
Estimating and Modeling Long Term Survival in Lung Cancer Using Mixture Parametric Models
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Lasting Responses After Discontinuation of Nivolumab Treatment for Reasons Other Than Tumor Progression in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer
Cancer Communications
Cancer Research
Oncology
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
JAMA Oncology
Cancer Research
Oncology
MA10.06 Impact of Immune-Related Adverse Events on Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Long-Term Survival of Locally Advanced Stage III Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy and Perspectives for the Treatment With Immunotherapy
Radiology and Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Nivolumab Improves Survival for Patients With Advanced Lung Cancer
Cancer
Cancer Research
Oncology
Small-Cell Lung Carcinoma With Long-Term Survival: A Case Report
Oncology Letters
Cancer Research
Oncology
Can Long-Term Survival Be Improved in Patients With Small-Cell Lung Cancer (SCLC) and Good Performance Status?
British Journal of Cancer
Cancer Research
Oncology
Efficacy of Nivolumab in Pre-Treated Non-Small-Cell Lung Cancer Patients Harbouring KRAS Mutations
British Journal of Cancer
Cancer Research
Oncology
